Form 4: Immunic Inc. Director Toernsen Reports Stock Option Repricing

Director Monika Maria Toernsen reports repricing of stock options at Immunic, Inc. following stockholder approval.

Summary

• On March 4, 2024, Immunic, Inc.'s stockholders approved a proposal to reduce the exercise price of eligible employee stock options to the greater of $1.72 or 110% of the closing price on a future repricing date.
• The Board of Directors set the repricing date as March 4, 2024, and determined the exercise price would be $1.72 per share.
• Director Monika Maria Toernsen reported the cancellation of existing eligible options and the reissuance of those options at the new exercise price of $1.72 per share.
• The repriced options retain their original vesting schedule and expiration date.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document simply reports a procedural change in stock option pricing, which is neither inherently positive nor negative.

Positives

• The repricing of stock options could incentivize employees and align their interests with those of shareholders.
• Lowering the exercise price to $1.72 makes the options more valuable to employees.

Industry Context

Stock option repricing is a common practice used by companies to incentivize employees, especially when the stock price has declined. It helps to maintain employee morale and retain talent.

Comparison to Industry Standards

• Stock option repricing is a fairly common practice, particularly among smaller biotech companies like Immunic, Inc.
• Many companies in the biotech sector use stock options as a significant part of their compensation packages.
• Repricing is often considered when the stock price falls significantly below the exercise price of outstanding options, making them less valuable to employees.

Stakeholder Impact

• The repricing of stock options may positively impact employees by increasing the value of their options.
• Shareholders may view the repricing as a positive step to retain and incentivize employees, potentially leading to long-term value creation.

Key Dates